These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27581601)

  • 1. A Comparative Evaluation of Hydroxycamptothecin Drug Nanorods With and Without Methotrexate Prodrug Functionalization for Drug Delivery.
    Guo F; Fan Z; Yang J; Li Y; Wang Y; Zhao H; Xie L; Hou Z
    Nanoscale Res Lett; 2016 Dec; 11(1):384. PubMed ID: 27581601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Targeted, Shape-Assisted, and Controlled-Release Self-Delivery Nanodrug for Synergistic Targeting/Anticancer Effect of Cytoplasm and Nucleus of Cancer Cells.
    Li Y; Lin J; Huang Y; Li Y; Yang X; Wu H; Wu S; Xie L; Dai L; Hou Z
    ACS Appl Mater Interfaces; 2015 Nov; 7(46):25553-9. PubMed ID: 26529185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
    Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
    ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a Janus role of methotrexate-based PEGylated chitosan nanoparticles in vitro.
    Luo F; Li Y; Jia M; Cui F; Wu H; Yu F; Lin J; Yang X; Hou Z; Zhang Q
    Nanoscale Res Lett; 2014; 9(1):363. PubMed ID: 25114653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
    Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
    ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Programmed Nanococktail Based on pH-Responsive Function Switch for Self-Synergistic Tumor-Targeting Therapy.
    Li Y; Song L; Lin J; Ma J; Pan Z; Zhang Y; Su G; Ye S; Luo FH; Zhu X; Hou Z
    ACS Appl Mater Interfaces; 2017 Nov; 9(45):39127-39142. PubMed ID: 29039650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-based amphiphilic prodrug nanoaggregates for co-administration of multiple therapeutics and synergistic cancer therapy.
    Hou M; Gao YE; Shi X; Bai S; Ma X; Li B; Xiao B; Xue P; Kang Y; Xu Z
    Acta Biomater; 2018 Sep; 77():228-239. PubMed ID: 30006314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug/Dye-Loaded, Multifunctional PEG-Chitosan-Iron Oxide Nanocomposites for Methotraxate Synergistically Self-Targeted Cancer Therapy and Dual Model Imaging.
    Lin J; Li Y; Li Y; Wu H; Yu F; Zhou S; Xie L; Luo F; Lin C; Hou Z
    ACS Appl Mater Interfaces; 2015 Jun; 7(22):11908-20. PubMed ID: 25978458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation the synergistic antitumor effect of methotrexate-camptothecin codelivery prodrug from self-assembly process to acid-catalyzed both drugs release: A comprehensive theoretical study.
    Pakdel M; Raissi H; Hosseini ST
    J Comput Chem; 2020 Jun; 41(16):1486-1496. PubMed ID: 32190916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of pH-sensitive methotrexate prodrug-targeted curcumin nanoparticles for efficient dual-drug delivery and combination cancer therapy.
    Xie J; Fan Z; Li Y; Zhang Y; Yu F; Su G; Xie L; Hou Z
    Int J Nanomedicine; 2018; 13():1381-1398. PubMed ID: 29563794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted rod-shaped mesoporous silica nanoparticles for the co-delivery of camptothecin and survivin shRNA in to colon adenocarcinoma in vitro and in vivo.
    Babaei M; Abnous K; Taghdisi SM; Taghavi S; Sh Saljooghi A; Ramezani M; Alibolandi M
    Eur J Pharm Biopharm; 2020 Nov; 156():84-96. PubMed ID: 32882423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus-shape design of polymer based drug delivery systems with janus-faced function for synergistic targeted drug delivery and more effective cancer therapy.
    Cui F; Lin J; Li Y; Li Y; Wu H; Yu F; Jia M; Yang X; Wu S; Xie L; Ye S; Luo F; Hou Z
    Mol Pharm; 2015 Apr; 12(4):1318-27. PubMed ID: 25710590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
    Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
    Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
    Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
    J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel methotrexate prodrug-targeted drug delivery system based on PEG-lipid-PLA hybrid nanoparticles for enhanced anticancer efficacy and reduced toxicity of mitomycin C.
    Li Y; Lin J; Wu H; Jia M; Yuan C; Chang Y; Hou Z; Dai L
    J Mater Chem B; 2014 Oct; 2(38):6534-6548. PubMed ID: 32261815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
    Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
    Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitomycin C-soybean phosphatidylcholine complex-loaded self-assembled PEG-lipid-PLA hybrid nanoparticles for targeted drug delivery and dual-controlled drug release.
    Li Y; Wu H; Yang X; Jia M; Li Y; Huang Y; Lin J; Wu S; Hou Z
    Mol Pharm; 2014 Aug; 11(8):2915-27. PubMed ID: 24984984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-sensibilized polymeric prodrug co-delivering MMP-9 shRNA plasmid for combined treatment of tumors.
    Tang Q; Ma X; Zhang Y; Cai X; Xue W; Ma D
    Acta Biomater; 2018 Mar; 69():277-289. PubMed ID: 29369806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
    Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
    Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-acting, function-responsive, and high drug payload nanospheres for combining simplicity and efficacy in both self-targeted multi-drug co-delivery and synergistic anticancer effect.
    Li Y; Lin J; Liu G; Ma J; Xie L; Guo F; Zhu X; Hou Z
    Int J Pharm; 2016 Oct; 512(1):194-203. PubMed ID: 27566011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.